Wire
Intelligent Bio Solutions Completes Precision Testing of Intelligent Fingerprinting Drug Screening System
Intelligent Bio Solutions (INBS) said Tuesday that it has completed precision testing of its Intelligent Fingerprinting Drug Screening System for detection of the opiate codeine.The company said that precision testing included over 1,600 tests across three production runs and three independent sites, with results showing repeatable, reproducible performance across all runs and sites.The company said that results from the testing will be included in its 510(k) submission to the US Food and Drug Administration for US market clearance.Shares of the company were up 5.6% in Tuesday's premarket trading.
$INBS
